There is a growing experience with positron emission tomography (PET) in patients with
pulmonary nodules or masses. As PET imaging becomes more widely available, it is …

In patients who have a high likelihood of having lung cancer, there is little role for positron
emission tomography (PET) imaging for diagnosis of the primary lesion. The primary impact …

Positron emission tomography (PET) imaging is an important tool to refine the diagnosis and
staging approach in patients with a possible lung cancer. In addition, other applications of …

Study objective: Positron emission tomography (PET) cancontribute to diagnosing and
staging lung cancer, but it has not beendetermined whether this information influences …

ContextFocal pulmonary lesions are commonly encountered in clinical practice, and
positron emission tomography (PET) with the glucose analog 18-fluorodeoxyglucose (FDG) …

Positron emission tomography (PET) represents a dramatic advance in the imaging of lung
cancer. It is valuable for the diagnosis, staging, prognosis, and restaging of disease, and is …

Positron emission tomography (PET) has been in existence and continuously developing
over the past 20 years. In the last few years steady advances in the technology used for PET …

PURPOSE Solitary pulmonary nodules (SPNs) are commonly identified by chest
radiographs and computed tomography (CT). Biopsies are often performed to evaluate the …

Introduction Positron emission tomography (PET) scanning has gained increasing
application as a diagnostic and staging tool in the evaluation of lung cancer. Although PET …

An estimated 180,000 new cases of lung cancer will be diagnosed in the United States this
year, and lung cancer accounts for approximately 25% of all cancer deaths. The overall 5 …